Descriptive epidemiology of malignant mesothelioma

Medicina del Lavoro

Volumn 96, Issue 4, 2005, Pages 287-303

  Bertazzi, Pier Alberto ^a,b  

^a Clinica del Lavoro L Devoto   (Italy)

^b PARKINSON INSTITUTE   (Italy)

Author keywords

Asbestos; Epidemiology; Mesothelioma; Review

Indexed keywords

AMPHIBOLE; ASBESTOS; CHRYSOTILE; CARCINOGEN;

AGE DISTRIBUTION; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; HUMAN; MALIGNANT MESOTHELIOMA; MEDICAL RECORD REVIEW; OCCUPATIONAL EXPOSURE; PLEURA MESOTHELIOMA; PROGNOSIS; RISK ASSESSMENT; SEX RATIO; SIMIAN VIRUS 40; TURKEY (REPUBLIC); UNITED STATES; EXPOSURE; HEALTH; INCIDENCE; LUNG TUMOR; MESOTHELIOMA; MORTALITY; OCCUPATIONAL DISEASE; PLEURA TUMOR; REVIEW; RISK FACTOR;

ASBESTOS; CARCINOGENS; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; INHALATION EXPOSURE; LUNG NEOPLASMS; MESOTHELIOMA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; RISK FACTORS; WORLD HEALTH;

EID: 33645061301     PISSN: 00257818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (83)

1. ALBIN M, MAGNANI C, KRSTEV S, et al: Asbestos and cancer: an overview of current trends in Europe. Environ Health Persp 1999; 107: s289-s298
2. ASCOLI V, MECUCCI C, KNUUTILA S: Genetic susceptibility and familial malignant mesotelioma (Letters). The Lancet 2001; 357: 1804
3. BANAEI A, AUVERT B, GOLDBERG M, et al: Future trends in mortality of French men from mesothelioma. Occup Environ Med 2000; 57: 488-494
4. BARIS B, DEMIR AU, SHEHU V, et al: Environmental Fibrous Zeolite (erionite) Exposure and Malignant Tumors Other than Mesothelioma. J Environment Path, Toxicol and Oncology 1996; 15: 183-186
5. BERRY M: Mesothelioma incidence and community asbestos exposure. Environ Res 1997; 75: 34-40
6. BERRY M: Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhalation Toxicology 1999; 11: 111-130
7. BERRY G, MUSK AW, DE KLERK NH, et al: Predictions of mortality from mesothelioma (Letters). Occup Environ Med 2003; 60: 458
8. BIANCHI C, BROLLO A, RAMANI L, et al: Asbestos exposure in malignant mesotelioma of the pleura: a survey of 557 cases. Ind Health 2001; 39: 161-167
9. BIANCHI C, GIARELLI L, GRANDI G, et al: Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cane Prev 1997; 6: 162-166
10. BOFFETTA P: Health effects of asbestos exposure in humans: a quantitative assessment. Med Lav 1998; 89: 471-480
11. BOURDÈS V, BOFFETTA P, PISANI P: Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Environmental exposure to asbestos and mesothelioma. Eur J Epidemiol 2000; 16: 411-417
12. BRITTON M: The epidemiology of mesothelioma. Semin Oncol 2002; 29: 18-25
13. BROWNE K: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure (Letters to the Editor). Ann Occup Hyg 2001; 45: 327-329
14. BURDORF A, DAHHAN M, SWUSTE P: Occupational characteristics of cases with asbestos-related diseases in The Netherlands. Ann Occup Hyg 2003; 47: 485-492
15. CAI SX, ZHANG CH, ZHANG X, et al: Epidemiology of occupational asbestos-related diseases in China. Ind Health 2001; 39: 75-83
16. CARBONE M, TESTA JR: Genetic susceptibility and familial malignant mesothelioma (Authors' reply - Letters). The Lancet 2001; 357: 1804
17. CARBONE M, KRATZKE R, TESTA JR: The pathogenesis of mesothelioma. Semin Oncol 2002; 29: 2-17
18. CERRANO PG, JASANI B, FILIBERTI R, et al: Simian virus 40 and malignant mesothelioma: Review. Int J Oncol 2003; 22: 187-194
19. COCCO PL, DOSEMECI M. Peritoneal cancer and occupational exposure to asbestos: results from applications of a job-exposure matrix. Am J Ind Med 1999; 35: 9-14
20. COMBA P, GIANFAGNA A, PAOLETTI L: Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health 2003; 58: 229-232
21. DOGAN AU, BARIS YI, EMRI S, et al: Familial malignant mesotelioma (Authors' reply - Letters). The Lancet 2001; 358: 1813-1814
22. DRISCOLL RJ, MULLIGAN WJ, SCHULTZ D, et al: Malignant mesothelioma: a cluster in a native American pueblo. N Engl J Med 1988; 318: 1437-1438
23. EDWARD AT, WHITAKER D, BROWNE, et al: Mesothelioma in a community in the North of England. Occup Environ Med 1996; 53: 547-552
24. EMRI S, KOCAGOZ T, OLUT A, et al: Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Research 2000; 20: 891-894
25. FERGUSON D: The rising epidemic of malignant mesothelioma (letter). Med J Australia 1989; 150: 607
26. FINNISH INSTITUTE OF OCCUPATIONAL HEALTH (FIOH). Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Consensus Report. Scand J Work Environ Health 1997; 23: 311-316
27. GILG SOIT ILG AGS, BIGNON J, VALLERON AJ: Estimation of the past and future burden of mortality from mesotelioma in France. Occup Environ Med 1998; 55: 760-765
28. GOVINDAN R: Management of Mesothelioma. (Conference Coverage). 10th World Conference on Lung Cancer. Vancouver, August 10-14, 2003
29. HEALTH AND SAFETY EXECUTIVE: Mesothelioma mortality in Great Britain: estimating the future burden. National Statistics. UK HSE, 2003
30. HEALTH EFFECTS INSTITUTE: Asbestos in public and commercial building: a literature review and synthesis of current knowledge. Cambridge, MA, 1991
31. HEMMINKI K, LI X: Time trends and occupational risk factors for peritoneal mesothelioma in Sweden. J Occup Environ Med 2003; 45: 451-455
32. HEMMINKI K, LI X: Mesothelioma incidence seems to have levelled off in Sweden. Int J Cancer 2003; 103: 145-146
33. HERNDON JE, GREEN MR, CHAHINIAN AP, et al: Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994. Chest 1998; 113: 723-731
34. HILLERDAL G: Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med 1999; 56: 505-513
35. HODGSON JT, DARNTON A: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44: 565-601
36. HODGSON J, DARNTON A: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure (Letters to the Editor). Ann Occup Hyg 2001; 45: 336-338
37. HOWIE RM: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure (Letters to the Editor). Ann Occup Hyg 2001; 45: 334-336
38. HUGHES JM, WEILL H: Asbestos exposure - Quantitative assessment of risk. Am Rev Respir Dis 1986; 133: 5-13
39. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER: IARC Monographs on the evaluation of carcinogenic risk of chemicals to man: Asbestos. Volume 14. Lyon: International Agency for Research on Cancer, World Health Organization, 1977
40. ISTITUTE NATIONAL DE SANTÉ ET RESEARCH MEDICAL: Effects sur la santé des principaux types d'exposition a l'amiante. Paris: INSERM, 1997: 434
41. KARJALAINEN A, PUKKALA E, MATTSON K, et al: Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1965. Scand J Work Environ Health 1997; 23: 266-270
42. KING JE, SWINDELL R, PICKERING CAC, et al: The North West Lung Center Experience of malignant pleural mesothelioma 1980-2000. Lung Cancer 2003; 41: S218
43. KJAERGAARD J, ANDERSSON M: Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health 2000; 26: 112-117
44. LA VECCHIA C, RECARLI A, PETO J, et al: An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev 2000; 9: 179-184
45. LEIGH J, DRISCOLL T: Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 2003; 9: 206-217
46. LIDDELL D: The quantitative risks of mesothelioma and lung cancer in relation to asbestos Exposure - Asbestos and cancer (Letters to the Editor). Ann Occup Hyg 2001; 45: 329-334
47. MAGNANI C, AGUDO A, GONZÁLEZ CA, et al: Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 2000; 83: 104-111
48. MAGNANI C, VICOMI S, DALMASSO P, et al: Survival after pleural malignant mesothelioma: a population-based study in Italy. Tumori 2002; 88: 266-269
49. MALLORY TB, CASTLEMAN B, PARRIS EE (eds): Case records of the Massachusetts General Hospital. Weekly clinicopathological Exercises. Case 33111. N Eng J Med 1947; 236: 407-412
50. MARINACCIO A, NESTI M AND REGIONAL OPERATION CENTERS: Analysis of survival of mesothelioma cases in the Italian Register (ReNaM). Eur J Cancer 2003; 39: 1290-1295
51. MCDONALD JC, MCDONALD AD: Epidemiology of mesothelioma. In Liddell D, Miller K (eds): Mineral Fibres and Health. Boca Raton: CRC Press, 1991: 147-168
52. MCDONALD JC, MCDONALD AD, ARMSTRONG B, et al: Cohort study of morality of vermiculite miners exposed to tremolite. Br J Ind Med 1986; 43: 436-444
53. MERLER E, LAGAZIO C, BIGGERI A: Andamento temporale della mortalità per tumore primitivo pleurico e incidenza del mesotelioma pleurico in Italia: una situazione particolarmente grave. [Trends in mortality from primary pleural tumours and incidence of pleural mesotelioma in Italy: a very serious situation]. Epidemiologia & Prevenzione 1999; 23: 316-326
54. METINTAS M, HILLERDAL G, METINTAS S: Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Eur Respir J 1999; 13: 523-526
55. METINTAS S, METINTAS M, UCGUN I, et al: Occupational and environmental lung disease. Malignant mesothelioma due to environmental exposure to asbestos. Follow-up of a Turkish cohort living in a rural Area. Chest 2002; 122: 2224-2229
56. MONTANARO F, BRAY F, GENNARO V, et al: Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes and Control 2003; 14: 791-803
57. MORINAGA K, HISHIMOTO T, SAKATANI M, et al: Asbestos-related lung cancer and mesothelioma in Japan. Ind Health 2001; 39: 65-74
58. NEUMANN V, GÜNTER S, MÜLLER KM, et al: Malignant Mesothelioma - German mesothelioma register 1987-1999. Int Arch Occup Environ Health 2001; 74: 383-395
59. NICHOLSON WJ: The carcinogenicity of chrysotile asbestos - A review. Ind Health 2001; 39: 57-64
60. NURMINEN M, KARJALAINEN A, TAKAHASHI K: Estimating the induction period of pleural mesothelioma from aggregate data on asbestos consumption. J Occup Environ Med 2003; 45: 1107-1115
61. ORENSTEIN MR, SCHENKER MB: Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med 2000; 6: 371-377
62. ORR KB: The rising epidemic of malignant mesothelioma (letter). Med J Australia 1989; 150: 607
63. PETO J, DECARLI A, LA VECCHIA C, et al: The European mesothelioma epidemic. Br J Cancer 1999; 79: 666-672
64. PETO J, SEIDMAN H, SELIKOFF J: Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 1982; 45: 124-135
65. PRICE B, WARE A: Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 2004; 159: 107-112
66. ROUSHDY-HAMMADY I, SIEGEL J, EMRI S, et al: Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. The Lancet 2001; 357: 444-445
67. SARACCI R, SIMONATO L: Familial malignant mesotelioma (Letters). The Lancet 2001; 358: 1813
68. SEGURA O, BURDORF A, LOOMAN C: Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003; 60: 50-55
69. SELÇUK ZT, ÇÖPLÜ L, EMRI S, et al: Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992; 102: 790-796
70. SELIKOFF IJ, LEE DHK: Asbestos and disease. New York: Academic Press, 1978: 262
71. SELIKOFF IJ, SEIDMAN H: Cancer risk in insulation workers in the United States. In Pogowski P, Gilson JC, Timbrell V, Wagner JC (eds): Biological effects of asbestos. Lyon: IARC Scientific Publication No. 8, WHO, 1973: 209-216
72. SLUIS-CREMER GK, LIDDELL FDK, LOGAN WPD, et al: The mortality of amphibole miners in South Africa, 1946-80. Be J Ind Med 1992; 49: 566-575
73. SMITH AH, WRIGHT CC: Chrysotile Asbestos is the main cause of pleural mesothelioma. Am J Ind Med 1996; 30: 252-266
74. SMITH DD: Women and Mesothelioma (Editorials). Chest 2002; 122: 1885-1886
75. SPIRTAS R, HEINEMAN EF, BERNSTEIN L, et al: Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994; 51: 804-811
76. STAYNER LT, DANKOVIC DA, LEMEN RA: Occupational exposure to chrysotile asbestos and cancer risk: A review of the amphibole hypothesis. Am J Pub Health 1996; 876: 179-186
77. STRICKER HD, GOEDERT JJ, DEVESA SS, et al: US pleural mesothelioma incidence rates following Simian virus 40 contamination of early poliovirus vaccines. J Nat Cancer Inst 2003; 95: 38-45
78. TAKAHASHI K, KARJALAINEN A: A cross-country comparative overview of the asbestos situation in ten Asian countries. Int J Occup Environ Health 2003; 9: 244-8
79. TOSSAVAINEN A: National mesothelioma incidence and the past use of asbestos. Monaldi Arch Chest Dis 2003; 59: 146-9
80. TREASURE T, WALLER D, SWIFT S, et al: Radical surgery for mesothelioma. The epidemic is still to peak and we need more research to manage it. Br Med J 2001; 328: 237-8
81. ULVESTAD B, KJAERHEIM K, MOLLER B, et al: Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003; 107: 94-98
82. WAGNER JC, SLEGGS CA, MARCHAND P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape province. Br J Ind Med 1960; 17: 260-271
83. WHITE C: Annual deaths from mesothelioma in Britain to reach 2000 by 2010 (Letters). Br Med J 2003; 326: 1417